High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Brazil Greenlights Five New Injectable Diabetes Drugs

Brazil's health regulator said ⁠it approved five new injectable GLP-1 drugs for diabetes and obesity treatment, ⁠following the expiration ⁠of Ozempic’s patent in ‌the country.

Statement Offers Guidance Around Incretin Prescribing

Consensus document from three European societies covers nutritional, functional, and psychological considerations for incretin-based therapies in adults.

T1D Onset Before Age 10 Tied to Higher Dementia Risk

Individuals with T1D diagnosed before the age of 10 years face a higher risk of developing dementia than those diagnosed later between ages of 18 and 30 years, a Swedish nationwide study shows.

Yo-Yo Dieting Accelerates Muscle Loss in Middle Age

Repeated episodes of weight loss and regain may be associated with a greater loss of muscle volume than keeping weight stable.

Urinary Incontinence May Lower Exercise Intensity in Women

More than 75% of women in a UK survey reported urinary incontinence, with those experiencing more severe symptoms engaging in less vigorous physical activity, study finds.

ART Regimen Drives Metabolic Variation in Pediatric HIV

The specific antiretroviral therapy regimen—not just HIV status—profoundly shapes the metabolic landscape in virally suppressed children living with HIV.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

Brazil's health regulator said ⁠it approved five new injectable GLP-1 drugs for diabetes and obesity treatment, ⁠following the expiration ⁠of Ozempic’s patent in ‌the country.

Consensus document from three European societies covers nutritional, functional, and psychological considerations for incretin-based therapies in adults.

Individuals with T1D diagnosed before the age of 10 years face a higher risk of developing dementia than those diagnosed later between ages of 18 and 30 years, a Swedish nationwide study shows.

Repeated episodes of weight loss and regain may be associated with a greater loss of muscle volume than keeping weight stable.

More than 75% of women in a UK survey reported urinary incontinence, with those experiencing more severe symptoms engaging in less vigorous physical activity, study finds.

The specific antiretroviral therapy regimen—not just HIV status—profoundly shapes the metabolic landscape in virally suppressed children living with HIV.

News All Time

Protein, Not Calcium, Key to Osteoporosis Treatment Benefits

Calcium supplementation may not add to the benefits of osteoporosis medications in older women with adequate calcium intake, but a low protein intake is linked to attenuated effects.

Thyroid Abnormalities Often Normalize in Pregnancy

Most pregnant women initially testing positive for subclinical hypothyroidism or hypothyroxinemia do not sustain abnormal thyroid function throughout pregnancy.

Desire to Lose Weight Linked to Unhealthy Behaviors

More than 60% of American adults want to weigh less, and those who do are significantly more likely to skip meals, use non-prescription supplements, or engage in purging behaviors.

Obesity and Cognitive Problems: Understanding the Connection

One can lead to the other. There are a number of reasons why.

Diet Program May Not Match Knee Surgery in Knee OA & Obesity

In patients with obesity and knee osteoarthritis eligible for knee arthroplasty, an intensive dietary weight-loss program is clinically inferior to surgery for patient-reported pain and function.

Increasing GLP-1 Use Raises Muscle Loss Concerns

Incretin mimetic therapy for obesity may reduce muscle mass and bone mineral density, but its effects on physical function and the risk for fractures in older adults remain uncertain.

Spermidine Intake Tied to Liver Health in Obesity and MetS

An increase in dietary spermidine intake over 1 year is associated with improvements in hepatic function and cardiometabolic health in older adults with overweight or obesity and metabolic syndrome.

USG Detects Vagus Nerve Atrophy in Parkinson's Disease

Ultrasound imaging reveals structural changes in the vagus nerve of patients with Parkinson's disease in a meta-analysis.

SGLT2-GLP-1 Combo Little Better Than Monotherapy in T2D

Using both SGLT2 inhibitors and GLP-1 receptor agonists is no more effective than using either drug alone in patients with type 2 diabetes, a new meta-analysis suggests.

Mindfulness-Based Eating Improves Anxiety, Eating Behavior

A mindfulness-based eating intervention improved anxiety, depression, and eating behaviors in adults with obesity and generalized anxiety disorder.

5 Common Lab Results: Why Context Matters

Common laboratory tests can mislead when interpreted without clinical context, highlighting why appropriate test selection matters as much as the results themselves.

Lilly Announces More Next-gen Obesity Drug Data, Plans Q1 2027 FDA Application

Eli Lilly said on Thursday that two more Phase 3 trials of its experimental obesity drug retatrutide showed positive results and it plans to submit ⁠an application to the...

Efforts Address Immune Suppression in Islet Cell Transplants

Updates suggest progress in the development of less-toxic regimens, and in gene editing to eliminate the need for immune suppression entirely.

Helping Patients With Diabetes Utilize Technology

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Will Semaglutide Prices Drop After 2026 Patent Expirations?

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Faricimab Reduces Shots, Improves Vision for Retinal Disease

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Recommended News For You

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

A large study found that monolayers were superior in detecting cancer.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Recommended Articles For You

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC 

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

2.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

3.

The top three drugs for multiple myeloma treatment upfront are four.

4.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

5.

Snus Linked to Gingival Damage, Raising Safety Questions

1.

Emerging Insights in Hematology for Better Care

2.

Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment

3.

Reconstructive Tissue Engineering After Tumor Resection

4.

The Importance of Maintaining Normal Calcium Levels in Your Body 

5.

Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot